Cardiomyopathy

• REVERT
  
• A-HEFT
  
• REVIVE
  
• ACTION
• OPT-CHF
• MD-CHF

  Cardiothoracic Surgery

• ACORN
• STICH

REVIVE - Principal Investigator: Flora Sam, MD

Multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of intravenous levosimendan in the short-term treatment (24 hours) of decompensated heart failure patients (NYHA III-IV with LVEF <35%) as compared to placebo.

Research Coordinator: Lorraine Keane, RN (617) 638-8060


Please click on a research project for more information.